In April we opened the world’s largest commercial human challenge trial unit in #CanaryWharf ! 🚀

🏙️ The FluCamp volunteers have enjoyed the new state-of-the-art quarantine facility!

📣Stay tuned for updates on the corporate office and laboratory move, coming soon!

#HVO

Our Chief Scientific Officer co-authored an article on results of inoculating healthy volunteers with the pre-alpha #SARSCoV2 strain in a CHIM where the volunteers had pre-existing serological antibodies to the virus, which featured in The Lancet:

thelancet.com/action/showPdf…

#HVO

We are attending BIO Convention on 3-6 June, in San Diego.

Meet with the team to learn about #HVO . Schedule a meeting via the One-on-One Partnering™ platform, or visit our booth located at the UK Pavilion stand 2025.

Learn more:
convention.bio.org/about-bio

#BIOConvention

We are looking to transform global #healthcare by revolutionising the #drugdevelopment process through scientific ingenuity.

Join us and deliver today’s healthcare by empowering tomorrow’s innovation.
youtube.com/watch?v=jlHTPW…

#Careers #Jobs #Recruiting #HVO

Our Senior Director of Business Development & Senior Director of Clinical Science will be attending the American Thoracic Society (ATS) Conference on 17-22 May.

Learn how #HVO delivers Human Challenge Trials with or proven track record & unparalleled heritage.

conference.thoracic.org

#ATS

Our Chief Scientific Officer caught up with Terrapinn at the World Vaccine Congress #WVC 24 in Washington:

🔬 Manufacturing agents at #HVO
🏙️ New Canary Wharf facility & impact on our clients
💉 Next generation vaccines
🦠 Overview of #WVC & presentation

youtube.com/watch?v=uw7aRx…

Hear our CEO's interview by the UK Investor Magazine at their event hosted at the LSEG (London Stock Exchange Group) in March.

Tune in to Mo's overview on hVIVO:
💪 Our company achievements
🔍 Why consider hVIVO
📈 2024 and beyond

linkedin.com/feed/update/ur…

#HVO

We are delighted to have been shortlisted for the European Mediscience Awards 2024!

🌟 Chief Executive of the Year Award

🌟 Best Communication Award

Learn more: mediscience-event.co.uk/nominations-ov…

MediscienceAwards #HVO #MediScienceAwards #EMA24

🌱Check out our 2023 ESG report!

At #HVO we promote health, diversity, and ethical business practices. Learn about our social initiatives, sustainability practices, and support for staff, volunteers, and ultimately patients here:

hvivo.com/environmental-…

#ESG #Sustainability

Our CEO & Business Development Director attended EBD Group #BIOAsia event in #Singapore this week.

The team was delighted to have met with many industry colleagues and continuing connections in the APAC region. 🚀

#HVO #APAC #Singapore #BIOAsia

Check out our #hLab team with the ViE Best Central/Specialty Laboratory Award, which #HVO was presented at the World Vaccine Congress #WVC in Washington.

Congrats to our #lab oratory team👨‍🔬⚗️🔬 for their hard work & dedication.

Learn more about our #lab services:
hvivo.com/laboratory-ser…

Our team looks forward to attending the 34th ESCMID (formerly known as #ECCMID ) event in #Barcelona , bringing together experts in the Clinical Microbiology & #InfectiousDiseases .

Meet with the team to discuss everything human challenge trials:
eccmid.org

#HVO

We are heading to #Singapore ✈️ to attend the #BIOAsia partnering forum, a conference focused on connecting biotech and pharma leaders from across the globe, with emerging innovators across Asia Pacific.

Meet with the team:
informaconnect.com/asia-bio-partn…

#HVO #BIOAsia #Conference

Our team is growing🚀We are delighted to introduce the appointment of Ian Meikle, Business Development Director, at #HVO . Ian has over 27 years of experience in the clinical CRO and laboratory services sector.

#NewHire #BusinessDevelopment

📢 If you missed our CEO & CFO presenting our full year results on Investor Meet Company earlier this week, you can watch the full recording here:

youtube.com/watch?v=k6d7_N…

#HVO #webinar

Our full year results featured in Investors' Chronicle:

🚀 hVIVO has strong upside potential – even using conservative targets

📈 Fast-growing research organisation reports record results and is set for another bumper year

Read it here:
investorschronicle.co.uk/ideas/2024/04/…

#HVO

Miss our #FY23 results? Catch up with Vox Markets interview:

💡 Financial & Operational highlights
📅 Annual Dividend Policy
🏙️ Canary Wharf Update
🏃‍♂️ Track to £62 million revenue guidance
🎯 £100 revenue target for 2028

youtube.com/watch?v=cX7vdd…

#HVO

Our CEO discusses this mornings results for year-end 31 December 2023 with Proactive

✅Financial highlights for 2023
✔️ Canary Wharf facility
✔️ On track to hit 2024 revenue guidance
🚀 Pathway to £100m revenue by 2028

Watch here:
youtube.com/watch?v=kcQRsP…

#HVO #AIM

Reminder 🔔 that our CEO & CFO will be presenting with Investor Meet Company this evening, 9 April, at 6pm BST to discuss #HVO 's full year results for the year ended 31 December 2023

Register here:
investormeetcompany.com/hvivo-plc-1/re…